Hypotonic hyporesponsive episode and the 13-valent pneumococcal vaccine

被引：0
|
作者：
Fotis, Lampros [1 ]
Vazeou, Andriani [1 ]
Xatzipsalti, Maria [1 ]
Stamoyannou, Lela [1 ]
机构：
[1] PA Kyriakou Childrens Hosp, Dept Pediat 1, Athens, Greece
来源：
TURKISH JOURNAL OF PEDIATRICS | 2014年 / 56卷 / 04期
关键词：
vaccine; adverse reactions; child; pneumococcal conjugate vaccine; hypotonia; C-REACTIVE PROTEIN; PERTUSSIS-VACCINE; PREMATURE-INFANTS; IMMUNIZATION; RESPONSES;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Hypotensive-hyporesponsive episodes are rare events after immunizations performed for diphtheria, tetanus, Haemophilus influenzae type b and hepatitis B virus vaccines, but most of the reported episodes have been associated with pertussis-containing vaccines. We report the case of a 3-month-old girl, previously healthy otherwise, presenting with the unusual event of a hypotonic-hyporesponsive episode after vaccination with the 13-valent pneumococcal vaccine. Diagnosis was established after a thorough evaluation of the patient and by exclusion of other clinical conditions.
引用
收藏
页码：427 / 429
页数：3
相关论文
共 50 条
  • [31] Advances in Pneumococcal Disease Prevention: 13-Valent Pneumococcal Conjugate Vaccine for Infants and Children
    Paradiso, Peter R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (10) : 1241 - 1247
  • [32] Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Yildirim, Inci
    Pelton, Stephen I.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 91 - 92
  • [33] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    [J]. VACCINE, 2012, 30 (28) : 4267 - 4275
  • [34] Use of the 13-valent pneumococcal conjugate vaccine in infants and young children
    Principi, Nicola
    Esposito, Susanna
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (05) : 641 - 648
  • [35] IMMUNOGENICITY OF 13-VALENT CONJUGATE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Caporuscio, S.
    D'Amelio, R.
    Nisini, R.
    Sorgi, M. L. L.
    Di Rosa, R.
    Salemi, S.
    Lagana, B.
    Canzoni, M.
    Milanetti, F.
    Caldarone, E.
    Teloni, R.
    Conti, F.
    Riccieri, V.
    Leraci, R.
    Spinelli, F. R.
    Valesini, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1023 - 1024
  • [36] Comments about the article: "Impact of the 13-valent pneumococcal conjugate vaccine"
    Panattieri, Nestor D.
    [J]. ARCHIVOS ARGENTINOS DE PEDIATRIA, 2016, 114 (06): : E486 - E486
  • [37] Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology
    Zhao, Alice S.
    Boyle, Sean
    Butrymowicz, Anna
    Engle, Robert D.
    Roberts, Jason M.
    Mouzakes, Jason
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (03) : 499 - 503
  • [38] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [39] BURDEN OF PNEUMONIA AFTER IMPLEMENTATION OF 13-VALENT CONJUGATE PNEUMOCOCCAL VACCINE
    Strachan, R.
    [J]. RESPIROLOGY, 2019, 24 : 99 - 99
  • [40] Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
    Tam, Pui-Ying Iroh
    Madoff, Lawrence C.
    Coombes, Brandon
    Pelton, Stephen I.
    [J]. PEDIATRICS, 2014, 134 (02) : 210 - 217
12345